Methods and compositions for controlled polypeptide synthesis

• US 7,968,519 B2
• Filed: 01/02/2008
• Issued: 06/28/2011
• Est. Priority Date: 03/19/1998
• Status: Expired due to Fees

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Wyrsta, Michael D., Deming, Timothy J., Curtin, Scott A., Seidel, Scott W., Hwang, Jungyeon, Yu, Miaoer, Nowak, Andrew
• Primary Examiner(s): Lukton; David
• Application Number:
  US12/006,440
• Publication Number:
  US 20080125581A1
• Time in Patent Office: 1,273 Days
• Field of Search: 530/324, 530/333, 514/21.2, 527/200
• US Class Current: 514/21.2
• CPC Class Codes: C07K 1/084 containing nitrogen
• CPC Class Codes: C07K 1/088 containing other elements, e.g. B, Si, As
• CPC Class Codes: C07K 1/10 using coupling agents C07K1/006 takes precedence
• CPC Class Codes: C07K 14/00 Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
• CPC Class Codes: C08G 69/10 Alpha-amino-carboxylic acids polysuccinimides C08G73/1092

Abstract

Methods and compositions for the generation of polypeptides having varied material properties are disclosed herein. Methods include means for initiating the polymerization of aminoacid-N-carboxyanhydride (NCA) monomer by combining the monomer with an amido-containing metallacycle, for making self assembling amphiphilic block copolypeptides and related protocols for adding oligo(ethyleneglycol) functionalized aminoacid-N-carboxyanhydrides (NCAs) to polyaminoacid chains. Additional methods include means of adding an end group to the carboxy terminus of a polyaminoacid chain by reacting an alloc-protected amino acid amide with a transition metal-donor ligand complex to forming an amido-amidate metallacycle for use in further polymerization reactions. Novel compositions for use in peptide synthesis and design including five and six membered amido-containing metallacycles and block copolypeptides are also disclosed.

Claims

1. A polypeptide composition comprising a block copolypeptide having:

(a) a total number of overall monomer units that is greater than about 100 amino acid residues; and

(b) a distribution of chain-lengths wherein Mw/Mn of the block copolypeptide is within the range of about 1.01 to about 1.25.

2. The composition of claim 1, wherein said block copolypeptide has a number of overall monomer units that is greater than about 250 amino acid residues.

3. The composition of claim 1, wherein said block copolypeptide comprises a least 3 blocks of consecutive identical amino acid monomer units.

4. The composition of claim 1, wherein at least one block of the block copolypeptide comprises γ

-benzyl-L-glutamate.

5. The composition of claim 1, wherein at least one block of the block copolypeptide comprises ε

-carbobenzyloxy-L-lysine.

6. The composition of claim 1, wherein said block copolypeptide is composed of amino acid components γ

-benzyl-L-glutamate and ε

-carbobenzyloxy-L-lysine.

7. The composition of claim 1, wherein said block copolypeptide is selected from the group consisting of a poly(ε

-benzyloxycarbonyl-L -Lysine-block-γ

-benzyl-L-glutamate), PZLL-b-PBLG, diblock copolymer and a poly(γ

-benzyl-L-glutamate-block-ε

-benzyloxycarbonyl-L-Lysine-block-γ

-benzyl-L-glutamate) triblock copolymer.

8. The composition of claim 1, wherein said block copolypeptide is an amphiphilic block copolypeptide comprising a soluble block polypeptide and an insoluble block polypeptide, said soluble block having at least about 30% mole percent identical amino acid residues having oligo(ethyleneglycol)-conjugated side chains and said insoluble block comprising at about 60 to 100 mole percent nonionic amino acid residues.

9. The composition of claim 8 wherein the insoluble block comprises about 3 to about 60 mole percent of the total copolypeptide.

10. The composition of claim 8 wherein the nonionic amino acid residues are selected from the group consisting of phenylalanine, leucine, valine, isoleucine, alanine and methionine.

11. The composition of claim 8 wherein the amino acid residues having oligo(ethyleneglycol)-conjugated side chains are selected from the group consisting of EG-cysteine, EG-lysine, EG-serine, and EG-tyrosine.

12. The composition of claim 1, wherein said block copolypeptide is a chain-end functionalized block polypeptide having ten or more consecutive identical amino acid residues and an endgroup selected from the group consisting of an oligosaccharide, oligonucleotide, fluoresent molecule, polymer chain, small molecule therapeutic, or reactive chemical linker to attach the block copolypeptide to another molecule.

13. The composition of claim 1, wherein said block copolypeptide is a chain-end functionalized block copolypeptide having an end group selected from the group consisting of a napthyl group, an alkyl group, an allyl group, and cysteinamide.

14. The composition of claim 1, wherein said block copolypeptide is an amphiphilic block copolypeptide comprising a soluble block polypeptide and an insoluble block polypeptide, said soluble block having at least about 30% mole percent identical amino acid residues having charged side chains and said insoluble block comprising at about 60 to 100 mole percent nonionic amino acid residues.

15. The composition of claim 14 wherein the insoluble block comprises about 3 to about 60 mole percent of the total copolypeptide.

16. The composition of claim 14 wherein the nonionic amino acid residues are selected from the group consisting of phenylalanine, leucine, valine, isoleucine, alanine and methionine.

17. The composition of claim 14 wherein the amino acid residues having charged side chains are selected from the group consisting of glutamic acid, aspartic acid, arginine, histidine, lysine, and ornithine.